Similar findings were also observed in prostate cancer for which Cav-1 overexpression significantly elevated glucose uptake and lactate production, and this was accompanied with upregulation of glucose transporter 3 and hexokinase 2. This evidence concerns the gene CAV1 and prostate cancer.